Michael Atkins
About
In The Last Decade
Michael Atkins
13 papers receiving 305 citations
Peers
Comparison fields: 5 of 62
- Oncology 178
- Immunology 177
- Molecular Biology 121
- Epidemiology 29
- Genetics 29
Countries citing papers authored by Michael Atkins
This map shows the geographic impact of Michael Atkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Atkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Atkins more than expected).
Fields of papers citing papers by Michael Atkins
This network shows the impact of papers produced by Michael Atkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Atkins. The network helps show where Michael Atkins may publish in the future.
Co-authorship network of co-authors of Michael Atkins
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Atkins. A scholar is included among the top collaborators of Michael Atkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Atkins. Michael Atkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 63 | |
| 6 | 40 | |
| 7 | 126 | |
| 8 | 9 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 11 | |
| 12 | 47 | |
| 13 | Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.